Advancing specificity in delirium : The delirium subtyping initiative
© 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association..
BACKGROUND: Delirium, a common syndrome with heterogeneous etiologies and clinical presentations, is associated with poor long-term outcomes. Recording and analyzing all delirium equally could be hindering the field's understanding of pathophysiology and identification of targeted treatments. Current delirium subtyping methods reflect clinically evident features but likely do not account for underlying biology.
METHODS: The Delirium Subtyping Initiative (DSI) held three sessions with an international panel of 25 experts.
RESULTS: Meeting participants suggest further characterization of delirium features to complement the existing Diagnostic and Statistical Manual of Mental Disorders Fifth Edition Text Revision diagnostic criteria. These should span the range of delirium-spectrum syndromes and be measured consistently across studies. Clinical features should be recorded in conjunction with biospecimen collection, where feasible, in a standardized way, to determine temporal associations of biology coincident with clinical fluctuations.
DISCUSSION: The DSI made recommendations spanning the breadth of delirium research including clinical features, study planning, data collection, and data analysis for characterization of candidate delirium subtypes.
HIGHLIGHTS: Delirium features must be clearly defined, standardized, and operationalized. Large datasets incorporating both clinical and biomarker variables should be analyzed together. Delirium screening should incorporate communication and reasoning.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Alzheimer's & dementia : the journal of the Alzheimer's Association - 20(2024), 1 vom: 18. Jan., Seite 183-194 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bowman, Emily M L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acute encephalopathy |
|---|
| Anmerkungen: |
Date Completed 18.01.2024 Date Revised 27.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/alz.13419 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360221122 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360221122 | ||
| 003 | DE-627 | ||
| 005 | 20240327235242.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/alz.13419 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1350.xml |
| 035 | |a (DE-627)NLM360221122 | ||
| 035 | |a (NLM)37522255 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bowman, Emily M L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Advancing specificity in delirium |b The delirium subtyping initiative |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.01.2024 | ||
| 500 | |a Date Revised 27.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association. | ||
| 520 | |a BACKGROUND: Delirium, a common syndrome with heterogeneous etiologies and clinical presentations, is associated with poor long-term outcomes. Recording and analyzing all delirium equally could be hindering the field's understanding of pathophysiology and identification of targeted treatments. Current delirium subtyping methods reflect clinically evident features but likely do not account for underlying biology | ||
| 520 | |a METHODS: The Delirium Subtyping Initiative (DSI) held three sessions with an international panel of 25 experts | ||
| 520 | |a RESULTS: Meeting participants suggest further characterization of delirium features to complement the existing Diagnostic and Statistical Manual of Mental Disorders Fifth Edition Text Revision diagnostic criteria. These should span the range of delirium-spectrum syndromes and be measured consistently across studies. Clinical features should be recorded in conjunction with biospecimen collection, where feasible, in a standardized way, to determine temporal associations of biology coincident with clinical fluctuations | ||
| 520 | |a DISCUSSION: The DSI made recommendations spanning the breadth of delirium research including clinical features, study planning, data collection, and data analysis for characterization of candidate delirium subtypes | ||
| 520 | |a HIGHLIGHTS: Delirium features must be clearly defined, standardized, and operationalized. Large datasets incorporating both clinical and biomarker variables should be analyzed together. Delirium screening should incorporate communication and reasoning | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a acute encephalopathy | |
| 650 | 4 | |a biomarkers | |
| 650 | 4 | |a clinical features | |
| 650 | 4 | |a cognitive change | |
| 650 | 4 | |a delirium | |
| 650 | 4 | |a endotype | |
| 650 | 4 | |a subphenotype | |
| 650 | 4 | |a subtype | |
| 700 | 1 | |a Brummel, Nathan E |e verfasserin |4 aut | |
| 700 | 1 | |a Caplan, Gideon A |e verfasserin |4 aut | |
| 700 | 1 | |a Cunningham, Colm |e verfasserin |4 aut | |
| 700 | 1 | |a Evered, Lis A |e verfasserin |4 aut | |
| 700 | 1 | |a Fiest, Kirsten M |e verfasserin |4 aut | |
| 700 | 1 | |a Girard, Timothy D |e verfasserin |4 aut | |
| 700 | 1 | |a Jackson, Thomas A |e verfasserin |4 aut | |
| 700 | 1 | |a LaHue, Sara C |e verfasserin |4 aut | |
| 700 | 1 | |a Lindroth, Heidi L |e verfasserin |4 aut | |
| 700 | 1 | |a Maclullich, Alasdair M J |e verfasserin |4 aut | |
| 700 | 1 | |a McAuley, Daniel F |e verfasserin |4 aut | |
| 700 | 1 | |a Oh, Esther S |e verfasserin |4 aut | |
| 700 | 1 | |a Oldham, Mark A |e verfasserin |4 aut | |
| 700 | 1 | |a Page, Valerie J |e verfasserin |4 aut | |
| 700 | 1 | |a Pandharipande, Pratik P |e verfasserin |4 aut | |
| 700 | 1 | |a Potter, Kelly M |e verfasserin |4 aut | |
| 700 | 1 | |a Sinha, Pratik |e verfasserin |4 aut | |
| 700 | 1 | |a Slooter, Arjen J C |e verfasserin |4 aut | |
| 700 | 1 | |a Sweeney, Aoife M |e verfasserin |4 aut | |
| 700 | 1 | |a Tieges, Zoë |e verfasserin |4 aut | |
| 700 | 1 | |a Van Dellen, Edwin |e verfasserin |4 aut | |
| 700 | 1 | |a Wilcox, Mary Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Zetterberg, Henrik |e verfasserin |4 aut | |
| 700 | 1 | |a Cunningham, Emma L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Alzheimer's & dementia : the journal of the Alzheimer's Association |d 2005 |g 20(2024), 1 vom: 18. Jan., Seite 183-194 |w (DE-627)NLM168942356 |x 1552-5279 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2024 |g number:1 |g day:18 |g month:01 |g pages:183-194 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/alz.13419 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2024 |e 1 |b 18 |c 01 |h 183-194 | ||